Pelthos Therapeutics, Inc. (PTHS)
23.12
+0.71
(+3.17%)
USD |
NYAM |
Mar 06, 16:00
23.30
+0.18
(+0.78%)
After-Hours: 20:00
Pelthos Therapeutics EPS Diluted (Quarterly) : -5.304 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.24M |
| Revenue (Quarterly) | 7.406M |
| Total Expenses (Quarterly) | 23.64M |
| Enterprise Value | 4.477M |
| Gross Profit Margin (Quarterly) | 54.31% |
| Profit Margin (Quarterly) | -219.3% |
| Earnings Yield | -61.38% |
| Normalized Earnings Yield | -61.38 |